Heterogeneity in disease activity, frequency of treatments, and visual outcomes among patients with retinal vein occlusion: relationship between injection need and vision with as-needed ranibizumab.
Robert B BhisitkulPeter A CampochiaroSteven BlotnerCarlos Quezada-RuizMimi LiuZdenka HaskovaPublished in: The British journal of ophthalmology (2024)
The BRVO/CRVO population is heterogenous with a varied response to ranibizumab treatment.